←Back to list

Valo Health

Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and deve
Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics.
Discovery Tools (Healthcare) 📍 Lexington, MA Founded 2019
Current Valuation
$1.4B
as of 2022-Q4
UNICORN

QL Price

$1.4B
0% vs last round
QuantLogix's current estimate for Valo Health, published 2026-09-11 — in line with the last disclosed round of $1.4B (2022-Q4).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round $1.4B 2022-Q4 weight 0.08
How this price has held up
No round has priced for Valo Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-11 and will be graded against the next priced round. See the full accuracy record →
How to actually get exposure to Valo Health →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Valo Health, 2026-09-11 (bc5992068a82b92d). The id pins this exact claim, so a citation stays checkable after the price moves. Model estimate for research — not a quote, target price, or investment advice.

IPO Outlookprivate

Is Valo Health going public?
No. Valo Health is private and has not filed to go public. There is no S-1 on file.
What is Valo Health's valuation in 2026?
Valo Health is valued at $1.4B as of 2022-Q4, set by its Series C ($100M, Oct 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Valo Health filed an S-1?
No public S-1 is on file for Valo Health.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

Founded
2019
HQ
Lexington, MA
Employees
186
Total Raised
$595M
Last Round
Series C — $100M (Oct 2022)
IPO Status
private

Fundraising Status

Series C · $100M · 3y 11mo ago
privateTotal raised $595M

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series C$100MOct 2022—$1.4B

Vertical Intelligence — Biotech / Gene Therapy

Registered trials
2
0 active · 0 recruiting
Lead phase
Phase 2
most advanced registered study
Focus areas
Myocardial Infarction
Non-proliferative Diabetic Retinopathy · Proliferative Diabetic Retinopathy
Latest trial start
2022-09
Name-verified against lead sponsor "Valo Health, Inc." on ClinicalTrials.gov as of 2026-09-03. Verify on ClinicalTrials.gov ↗

Talent Signal

Hiring trend
▼ Hiring downtrend
0% of roles posted in last 30d
Open roles
3
via greenhouse
Product-build share
67%
engineering, research, product, design
Trajectory
strengthening
heavy product build — 67% of open roles are product-building functions (engineering/research/product) — 2 of 3 open roles are research.
Recent senior hire: 1 senior hire (CFO); open roles trending down.
Open roles by month
Open roles by month3Aug '26
Open roles by function
Open roles by functionResearch2Other1
■ product-building   ■ go-to-market / G&A
Key Executive Moves
INRita KaleCFO · 2026-08-14
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
Staff Data Scientist, Computational BiologyStaff Data Scientist, Machine Learning in Epidemiology and Patient Data ProductsAssociate Director, Laboratory Informatics and Platform Automation
Counted from Valo Health's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
BiotechnologyHealth CareInformation Technology
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q4. Refreshed quarterly.